The Certificate in Psilocybin-Assisted Therapy is a program designed for therapists seeking to obtain the training and education necessary to become a licensed Psilocybin Facilitator under Oregon’s Measure 109.
Fluence
English
42 Hours
The Certificate in Psilocybin-Assisted Therapy is a program designed for therapists seeking to obtain the training and education necessary to become a licensed Psilocybin Facilitator under Oregon’s Measure 109. The program is grounded in Fluence’s Psychedelic Harm Reduction and Integration (PHRI) approach and is taught by leading experts with psilocybin-assisted therapy experience in clinical research settings. It includes 120 hours of instruction in mixed in-person, online asynchronous, and online synchronous formats, plus a 40-hour practicum experience for a total of 160 hours.
The program is licensed by the Oregon Higher Education Coordinating Commission and has received curriculum approval from the Oregon Health Authority. The program includes two courses: Psilocybin-assisted Therapy Part 1, and Psilocybin-assisted Therapy Part 2, and will take place over 30 weekly sessions, in small groups of around 12 participants. The program also includes an in-person course "Trauma-informed Psychedelic-assisted Therapy" which will be scheduled at least twice a year. Participants will also have access to an online classroom with resources, schedules, and opportunities for collaboration.
Upon completion of the program, participants will be eligible for the OHA’s Psilocybin-facilitator’s Licensing Exam.
Applications were open until late 2023, but no new cohorts have been announced.
Therapists seeking training to become licensed Psilocybin Facilitators under Oregon’s Measure 109.
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
By Therapsil
A 106-hour live online training in psilocybin-assisted psychotherapy with an Aotearoa New Zealand-specific curriculum, delivered in partnership with PsyTrain. It is designed to support clinical practice with supervised learning and expert faculty input.
Next cohort: Jun 1, 2026
By Synthesis
An 8-day immersive apprenticeship retreat in the Netherlands focused on ethical psychedelic facilitation and group space-holding. Participants observe, support, and reflect within a clinically informed, somatically intelligent training structure.